NCT03290495

Brief Summary

Ketamine effect on isoflurane anesthesia This study is designed to study the effect of ketamine on isoflurane anesthesia. As both drugs are hypnotic and are used to cause sleep during surgery and other painful procedures, it was long believed that the actions of two drugs add to each other. For example if a man received both drugs, this man will become awake from anesthesia much later than if this man was given either of them alone. However recent studies showed that this is not the case and ketamine can cause fast recovery from hypnotic effects of isoflurane. This was confirmed in animals. The aim of current study is to investigate if this effect applies for humans, using a state of art brain monitoring device in wide use nowadays called BIS or bispectral index. This device can also shed some light on how ketamine can cause, if any, fast recovery from isoflurane anesthesia. Simply, by studying electrical wave coming from brain to head skin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Sep 2017

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2017

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 25, 2017

Completed
5 days until next milestone

Study Start

First participant enrolled

September 30, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2017

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 25, 2017

Completed
Last Updated

November 28, 2017

Status Verified

November 1, 2017

Enrollment Period

2 months

First QC Date

September 8, 2017

Last Update Submit

November 25, 2017

Conditions

Keywords

ketamineisofluraneelectroencephalographymaintenancerecoveryanesthesia

Outcome Measures

Primary Outcomes (1)

  • recovery time

    recovery time in this study is defined as time between stop of isoflurane inhalation and recovery of consciousness . this will be assessed by calling the patient first name loudly until the patient verbally respond.time will be recorded in seconds.

    Time Frame: 1 hour

Secondary Outcomes (2)

  • gamma wave activity

    Time Frame: 2 hour

  • processed EEG parameters

    Time Frame: 2 hour

Study Arms (2)

isonly

ACTIVE COMPARATOR

This arm will receive spinal anesthesia. then this arm will receive saline during isoflurane anesthesia. this arm will serve as a control group.

Drug: saline

isoket

ACTIVE COMPARATOR

this arm will receive spinal anesthesia. then will receive isoflurane inhalation. during isoflurane inhalation, this arm will receive single injection of ketamine. at end of anesthesia, effect of ketamine on recovery will be monitored.

Drug: ketamine

Interventions

ketamine hydrochloride 250microgram/ ml for iv injection after 30 minutes of stable isoflurane anesthesia

Also known as: Calypsol
isoket
salineDRUG

a similar volume of normal saline 0.9% for intravenous injection instead of ketamine will be given to the control group. this because the attending anesthesiologist will be blinded to the study drugs and aim according to the study proposal.

Also known as: normal saline, Atsuka
isonly

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consent: patient must be legally fit to consent. Informed consent will be get from each patient.
  • ASA status: I or II.
  • Fully conscious at time of induction of anesthesia.
  • No history of side effects related to any drugs used in the study.
  • Planned surgery can be performed under spinal anesthesia

You may not qualify if:

  • Incompetence: failure to give informed consent or refusal.
  • Neurological or psychiatric disorders
  • Addiction
  • Recent intake of drugs affecting central nervous system
  • ASA state more than II
  • Morbid obesity
  • Surgery cannot solely performed under spinal anesthesia
  • Contraindication to spinal anesthesia as coagulopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minia University Hospital (main hospital)-kornish elnil st.

Minya, Minya Governorate, 61511, Egypt

Location

Related Publications (5)

  • Li D, Hambrecht-Wiedbusch VS, Mashour GA. Accelerated Recovery of Consciousness after General Anesthesia Is Associated with Increased Functional Brain Connectivity in the High-Gamma Bandwidth. Front Syst Neurosci. 2017 Mar 24;11:16. doi: 10.3389/fnsys.2017.00016. eCollection 2017.

    PMID: 28392760BACKGROUND
  • Mashour GA. Cognitive unbinding: a neuroscientific paradigm of general anesthesia and related states of unconsciousness. Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2751-9. doi: 10.1016/j.neubiorev.2013.09.009. Epub 2013 Sep 26.

    PMID: 24076246BACKGROUND
  • Philip BK, Kallar SK, Bogetz MS, Scheller MS, Wetchler BV. A multicenter comparison of maintenance and recovery with sevoflurane or isoflurane for adult ambulatory anesthesia. The Sevoflurane Multicenter Ambulatory Group. Anesth Analg. 1996 Aug;83(2):314-9. doi: 10.1097/00000539-199608000-00019.

    PMID: 8694311BACKGROUND
  • Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ. 1995 Oct 28;311(7013):1145-8. doi: 10.1136/bmj.311.7013.1145.

    PMID: 7580713BACKGROUND
  • Florey CD. Sample size for beginners. BMJ. 1993 May 1;306(6886):1181-4. doi: 10.1136/bmj.306.6886.1181.

    PMID: 8499826BACKGROUND

MeSH Terms

Interventions

KetamineSodium ChlorideSaline Solution

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Mamdouh H Hassan, MD

    Minia faculty of Medicine. Minia university. Egypt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The patients well be randomized to one of the two groups by closed envelope technique. After opening the envelope, the study drug (ketamine 100µg/kg total body weight (Isoket group)) or normal saline ((Isonly) or control group) will be prepared, made up to 10 ml and administered by an assistant in the proper timing. The patient identification will be written on a slip and put back into an envelope and sealed. The person doing the procedure and monitoring along with the patient will be blinded to the dose and nature of solution. The equal volume test solution will be given intravenously by an assistant who was not involved in the administration of anesthesia and monitoring
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: An intravenous catheter was placed and normal saline (0.9%) will be infused. Spinal anesthesia will be given. The stability of spinal anesthesia will be assured before propofol injection and at the end of procedure. Propofol will be given to facilitate isoflurane inhalation which will be varied between 0.8-1.2percent to keep (BIS) in the range 40-60. Anesthesia will be kept as so for 30 minutes. Then the test drug (either ketamine or saline) will be given slowly, to pressor response in case of ketamine. Anesthesia will be maintained for another 30 minutes then isoflurane is discontinued. Recovery from anesthesia will then be tested.. No other drugs will be routinely given. Development of complications or signs of inadequate anesthesia will cause drop of the case from study and any measures will be taken to insure patient safety and comfort.The patient will be let to recover from anesthesia then transferred to postoperative care unit.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of anesthesia and intensive care

Study Record Dates

First Submitted

September 8, 2017

First Posted

September 25, 2017

Study Start

September 30, 2017

Primary Completion

November 15, 2017

Study Completion

November 25, 2017

Last Updated

November 28, 2017

Record last verified: 2017-11

Locations